Improving Clinician Communication Skills (ICCS)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Advanced Cancer
Related studies linked through entity extraction aliases.
Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain
- Status
- TERMINATED
- Phase
- PHASE2
Patient and Family Decision Making in the Palliative Care Setting
- Status
- COMPLETED
- Phase
- NA
Rapamycin Plus Bevacizumab in Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of MKC-1 in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ARRY-334543 in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Spirituality/Religiosity in Patients and Caregivers
- Status
- COMPLETED
- Phase
- N/A
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
- Status
- TERMINATED
- Phase
- PHASE3
Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Multimodal Treatment Strategy for Cancer Cachexia
- Status
- TERMINATED
- Phase
- NA
Interactive Voice Response System in Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Oral Palifosfamide Tris in Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1